[FATE] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
09-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -12.50%
YoY- -6.29%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 2,632 1,026 1,027 1,322 0 0 472 33.14%
PBT -19,760 -14,135 -10,126 -8,377 -7,881 -6,980 -3,548 33.12%
Tax 1,091 331 111 27 1 0 100 48.89%
NP -19,760 -14,135 -10,126 -8,377 -7,881 -6,980 -3,548 33.12%
Tax Rate - - - - - - - -
Total Cost 22,392 15,161 11,153 9,699 7,881 6,980 4,020 33.12%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin -750.76 -1,377.68 -985.98 -633.66 0.00 0.00 -751.69 -0.02%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -0.30 -0.27 -0.24 -0.29 -0.38 -0.34 -0.40 -4.67%
EPS Diluted -0.30 -0.27 -0.24 -0.29 -0.38 -0.34 -0.40 -4.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.